Daniel Lyons, PhD

Daniel Lyons is a portfolio manager and research analyst at Janus Henderson Investors focusing on the biotechnology, diagnostics, and life science tool industries. Dr. Lyons started consulting for Janus in February 1997 and joined the health care team full time in September 2000. He received his Bachelor of Arts degree in biochemistry and chemistry, graduating magna cum laude, from Rice University. Dr. Lyons also earned a Ph.D. from Stanford University’s Program in Immunology and conducted postdoctoral research with a Nobel laureate at the University of Colorado. He holds the Chartered Financial Analyst designation and has 19 years of financial industry experience. Following his research in immunology he had a strong interest in children’s health advancement through vaccination.

Immunize Colorado